Home - Products - Others - Other Targets - 6-Methoxynaringenin-7-O-β-D-glucoside

6-Methoxynaringenin-7-O-β-D-glucoside

CAS No. 1351949-09-1

6-Methoxynaringenin-7-O-β-D-glucoside( ——— )

Catalog No. M38259 CAS No. 1351949-09-1

6-Methoxynaringenin-7-O-β-D-glucoside is a methoxynaringenin that can be isolated from Salvia plebeia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Methoxynaringenin-7-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Methoxynaringenin-7-O-β-D-glucoside is a methoxynaringenin that can be isolated from Salvia plebeia.
  • Description
    6-Methoxynaringenin-7-O-β-D-glucoside is a methoxynaringenin that can be isolated from Salvia plebeia.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1351949-09-1
  • Formula Weight
    464.42
  • Molecular Formula
    C22H24O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bang S, et al.?2. Lee G T, et al. Phytochemical constituents from Salvia plebeiaJ. Natural Product Sciences, 2010, 16(4): 207-210.
molnova catalog
related products
  • PACMA 31

    PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.

  • Beta-Tocotrienol

    Beta-Tocotrienol to serve as a new anticancer agent for treating human lung and brain cancers. It inhibits the growth of both A549 (GI50=1.38±0.334μM) and U87MG (GI50=2.53±0.604μM) cells at rather low concentrations.

  • MARK4 inhibitor 1

    MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?